Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03804996
Title Study of TG-1801 in Subjects With B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors TG Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
TG Therapeutics Investigational Trial Site Heidelberg Victoria 03084 Australia Details
TG Therapeutics Investigational Trial Site Melbourne Victoria Australia Details
TG Therapeutics Investigational Trial Site Nedlands Western Australia 06009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field